title: Hyperkeratosis and leukocytosis in transgenic mice carrying MHC class I chain-related gene B (MICB).
abstract: Major histocompatibility complex (MHC) class I chain-related gene A and B (MICA and MICB) are located very close to HLA-B. MICA is reported to be strongly associated with Behçet's disease (BD), a multisysytemic inflammation disorder characterized by oral apthous ulcers, skin lesions and genital ulcers. These two molecules are highly conserved at the amino acid levels. To determine the function of MICB in vivo and the relationship between the expression of MICB and BD experimentally, we produced several transgenic mouse lines (termed CAG-MICB) expressing human MICB cDNA under a ubiquitous promoter. They exhibited a 50% increase in the number of white blood cells compared with their non-transgenic littermates, and also exhibited a 10-20% reduction in body weight compared with non-transgenic littermates. Exfoliation of the skin first appeared around 7 days after birth and disappeared after 2 weeks of age. This was repeatedly observed in the transgenic offspring of two independent CAG-MICB lines examined. Histopathological analysis of skin of young mice exhibiting skin abnormalities revealed hyperkeratosis of the epidermis and thickening of the granular layer with slight infiltration of inflammatory cells in the dermis without any vasculitis. Other remarkable abnormalities associated with BD have not been observed in the CAG-MICB lines. Furthermore, fluorescein angiography of eyes of the CAG-MICB lines was performed, but there were no marked changes of BD-related uveitis in the ocular fundus. These findings suggest that (i) MICB expression is related to temporary skin inflammation, and (ii) expression of MICB is not directly associated with BD.
authors.affiliation: Department of Genetic Information, Division of Molecular Life Science, Tokai University School of Medicine, Kanagawa, Japan.
authors.forename: E
authors.initials: E
authors.lastname: Nomura
authors.forename: M
authors.initials: M
authors.lastname: Sato
authors.forename: H
authors.initials: H
authors.lastname: Suemizu
authors.forename: T
authors.initials: T
authors.lastname: Watanabe
authors.forename: T
authors.initials: T
authors.lastname: Kimura
authors.forename: K
authors.initials: K
authors.lastname: Yabuki
authors.forename: K
authors.initials: K
authors.lastname: Goto
authors.forename: N
authors.initials: N
authors.lastname: Ito
authors.forename: S
authors.initials: S
authors.lastname: Bahram
authors.forename: H
authors.initials: H
authors.lastname: Inoko
authors.forename: N
authors.initials: N
authors.lastname: Mizuki
authors.forename: S
authors.initials: S
authors.lastname: Ohno
authors.forename: M
authors.initials: M
authors.lastname: Kimura
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D015395:Histocompatibility Antigens Class I / Q000235:genetics*; D006801:Humans; D017488:Hyperkeratosis, Epidermolytic / Q000235:genetics* / Q000503:physiopathology; D007964:Leukocytosis / Q000235:genetics*; D051379:Mice; D008822:Mice, Transgenic
chemical_list: D015395:Histocompatibility Antigens Class I; C098080:MICB antigen